Aug 5, 2022
Political portrait of PhrMA CEO Steve Ubl.
seen from Malaysia
seen from Malaysia
seen from United States
seen from United States
seen from Italy
seen from United States
seen from United States
seen from United States
seen from United Kingdom
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from Italy
seen from United Kingdom
seen from United States
seen from United States
seen from Albania
seen from China
Political portrait of PhrMA CEO Steve Ubl.
PHRMA is going hard against Medicare negotiating lower drug prices. Just say a commercial where a mother of a kid with cancer claimed "government price setting" as stifling innovation and research. In other words, if you don't let them price gouge they will cut research, killing kids with cancer and their hope. Because of course profits for investors cannot be touched even if it means people go without their medications.
In TV ads, the pharmaceutical industry claims congressional plans to allow the federal government to negotiate drug prices in Medicare would deny beneficiaries' access to medicines their doctors prescribe. Experts say that's unlikely, and an inaccurate portrayal of recent legislation.
Big pharma is blaming others in the drug supply chain while pushing policies to protect its own bottom line.
#thewaronyou
i’m here now!!! buy me a drink? haha.....
EXCLUSIVE: Brian Toohey, of the Pharmaceutical Research and Manufacturers of America trade group, spearheads PhRMA and recently told of the US drugs industry's predatory intentions
SCUM! Brian Toohey of the Pharmaceutical Research and Manufacturers of America trade group.
Big Pharma - Big Money: Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America (PhRMA), the pharmaceutical industry’s largest trade association, floods the American government with millions of dollars to knock down medication price control measures.
The drug industry has waged a widespread campaign to influence American policy, lobbing both sides of the aisle. PhRMA brought in a record $459 million from drugmakers in 2018. They are using that funding to fight drug pricing proposals from congressional Democrats, Democratic candidates, and even the Trump administration. The top recipients of PhRMA funding were conservative groups that work to combat “socialist” price controls.
top recipients
American Action Network: the conservative dark money group, took in $10 million from PhRMA since 2016, who invariably advocate pro-drugmaker policies. In August 2019 AAN launched a $2.5 million ad campaign to fight “socialist” price controls in Medicare Part D. In June, AAN launched a $3 million ad campaign in support Trump’s proposed drug rebate rule (pulled in July).
The National Sheriff’s Association, which represents thousands of elected sheriffs, received at least $900,000 in grants from the Partnership for Safe Medicines (a nonprofit funded by PhRMA) ran a six-figure television ad campaign urging Trump to reject proposals that allowed the importation of generic prescription drugs from Canada.
The Council for Affordable Health Coverage: a lobbying organization representing health industry stakeholders including drug companies, took in $725,000 from PhRMA between 2017 and 2018. CAHC took part in a “listening session,” at White House in July urging against drug price controls.
The American Conservative Union, a righ-wing advocacy group, received $150,000 from PhRMA in 2017, then lobbied lawmakers not to adopt “socalist policies” that would control drug prices.
FreedomWorks: the conservative dark money group, received $100,000 from PhRMA in 2018 and then ran a digital ad campaign fighting “the socialist rate-setting scheme.” They signed on to the November 2018 letter opposing the Trump administration’s proposed rule to create price controls for drugs administered under Medicare Part B.
Consumer Action for a Strong Economy: a Koch backed Super PAC received $170,000 from PhRMA signed the November 2018 letter opposing the Trump administration’s proposed rule to create price controls for drugs administered under Medicare Part B.
Taxpayers Protection Alliance: a Koch backed advocacy group, received $65,000 from PhRMA also signed the November 2018 letter opposing the Trump administration’s proposed rule to create price controls for drugs administered under Medicare Part B.
Institute for Policy Innovation: a conservative a think tank, received $35,000 from PhRMA also signed the November 2018 letter opposing the Trump administration’s proposed rule to create price controls for drugs administered under Medicare Part B.
Competitive Enterprise Institute: a right-wing advocacy group, received $25,000 from PhRMA also signed the November 2018 letter opposing the Trump administration’s proposed rule to create price controls for drugs administered under Medicare Part B.
Heritage Action for America: a conservative PAC, received $37,500 in 2018 from PhRMA and then ran ads aimed at Congressional Reps to reject the “socialist” price control measures.
top candidate recipients
$90,500 Total in Contributions from this PAC to federal candidates - 2020 cycle (49% to Democrats, 51% to Republicans)
Schrader, Kurt (D-OR) - $6,000
Graham, Lindsey (R-SC) - $4,000
Eshoo, Anna (D-CA) - $3,500
Kind, Ron (D-WI - )$3,000
Murphy, Stephanie (D-FL) - $2,500
Bucshon, Larry (R-IN) - $2,500
Collins, Doug (R-GA) - $2,000
Kelly, Mike (R-PA) - $2,000
Kuster, Ann (D-NH) - $2,000
Nunes, Devin (R-CA) - $2,000
Peters, Scott (D-CA - )$2,000
Cassidy, Bill (R-LA) - $2,000
Gardner, Cory (R-CO) - $2,000
(adsbygoogle = window.adsbygoogle || []).push({});
source:
Opensecrets.org, Big Pharma bankrolled conservative groups that pushed industry message to Trump, tax returns show, Karl Evers-Hillstrom, November 15, 2019 https://www.opensecrets.org/news/2019/11/big-pharma-bankrolled-conservative-groups-tax-returns-show/
Opensecrets.org, Pharmaceutical Research & Manufacturers of America, November 21, 2019 https://www.opensecrets.org/orgs/summary.php?id=D000000504
STAT News, ‘Don’t be a Bernie Bro’: Inside conservatives’ brazen campaign to sabotage Trump’s signature drug pricing plan, Lev Facher, July 29, 2019 https://www.statnews.com/2019/07/29/conservative-campaign-against-drug-prices/
The American Action Network, AAN Launches $2.5 Million Campaign Opposing Socialist Price Controls in Medicare Part D, August 26, 2019 https://americanactionnetwork.org/press/aan-launches-2-5-million-campaign-opposing-socialist-price-controls-in-medicare-part-d/
On the #Megabus to #WashingtonDC to deliver a presentation at #PhRMA headquarters. https://www.instagram.com/p/B2hTYmShMXR/?igshid=xcrq8fs037ad